UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
The University of California, Riverside, expects to receive a shipment of 400 Moderna COVID-19 vaccine doses on Wednesday, Jan. 20. An initial shipment of 100 Moderna vaccines was delivered to Student Health Services earlier this month in order to begin inoculating frontline health care staff.
Members of the COVID-19 Response and Recovery Task Force updated faculty and staff on the progress of UCLA Health's vaccination program and to take questions.
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive indicators for persons at risk for recurrent major depressive disorder.
Paul Boutros, PhD, Robert Reiter, MD, and Huihui Ye, MD, MS, of the UCLA Jonsson Comprehensive Cancer Center have received the 2020 Prostate Cancer Foundation Special Challenge Award to help improve the understanding of prostate cancer biology and identify new ways to help prevent, diagnose, prognose and treat lethal prostate…
Scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a technique that will enable researchers to more efficiently isolate and identify rare T cells that are capable of targeting viruses, cancer and other diseases.
Health Media Contacts
Find the best contact for health-related media inquiries.
